Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
4.930
+0.110 (2.28%)
At close: Aug 13, 2025, 4:00 PM
4.510
-0.420 (-8.52%)
Pre-market: Aug 14, 2025, 8:03 AM EDT
Titan Pharmaceuticals Employees
Titan Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,052,250
Market Cap
5.82M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | 0 | - |
Dec 31, 2022 | 4 | -7 | -63.64% |
Dec 31, 2021 | 11 | -1 | -8.33% |
Dec 31, 2020 | 12 | -9 | -42.86% |
Dec 31, 2019 | 21 | -2 | -8.70% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TTNP News
- 8 days ago - TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP - Business Wire
- 6 weeks ago - Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 2 months ago - Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. - GlobeNewsWire
- 4 months ago - Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 9 months ago - Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire